Human apolipoprotein (apo) E plays an important role in the metabolism of cholesterol and other lipids. Apo E5 and apo E7 are genetic variants of apo E and have been detected in about 5~ of Japanese patients with hyperlipidemia and ischemic heart disease. The existence of apo E5 and apo E7, however, had not been reported in apparently healthy individuals except for a few family members of the patients with apo E5 or apo E7. It has been suggested that apo E5 and apo E7 are closely related to the development of atherosclerosis. The purpose of this study is to investigate the frequency of apo E5 and apo E7 in apparently healthy Japanese and to analyze serum lipid levels of the individuals with apo E5 or apo E7.
Human apolipoprotein (apo) E plays an important role in the metabolism of cholesterol and other lipids. Apo E5 and apo E7 are genetic variants of apo E and have been detected in about 5~ of Japanese patients with hyperlipidemia and ischemic heart disease. The existence of apo E5 and apo E7, however, had not been reported in apparently healthy individuals except for a few family members of the patients with apo E5 or apo E7. It has been suggested that apo E5 and apo E7 are closely related to the development of atherosclerosis. The purpose of this study is to investigate the frequency of apo E5 and apo E7 in apparently healthy Japanese and to analyze serum lipid levels of the individuals with apo E5 or apo E7.
The apo E phenotypes of 197 apparently healthy Japanese adults were determined by two-dimensional gel electrophoresis. The gene frequencies ofapo E were: ~3, 0.843; ~4, 0.112; ~2, 0.038; e5, 0.006; ~7, 0.0035 . Three out of 187 subjects (1.5~) were found to have apo E5 or apo E7 in heterozygous state. Two of them were heterozygous with apo E3 (apo E3/5 and apo E3/7) and the both had normal serum lipid levels, though they were more than 50 years old. The other individual was heterozygous with apo E2 (apo E2/5) and had mild hypertriglyceridemia. As to myocardial infarction, angina pectoris and cerebral infarction, no clinically abnormal findings were detected in all the three individuals with apo E5 or apo E7.
The data suggest that the frequency of the individuals with apo E5 or apo E7 is of the order of 1 X and much higher than that of the homozygotes with apo E2/2 in Japanese. The data also indicate that further genetic, epidemiologic and clinical studies are required to determine whether ~5 and ~7 act as a dominant major gene, as a recessive major gene, or as INTRODUCTION Apolipoprotein (Apo) E is a major protein constituent of human plasma very low density lipoproteins (VLDI_) (Shelburne and Quarfordt, 1974) . It is also a normal constituent of chylomicrons and a subfraction of the high density lipoproteins (HDL) (Weisgraber and Mahley, 1978; Mahley and Innerarity, 1983) . Human apo E is a single chain polypeptide (Mr 34,000) of 299 amino acids and its complete amino acid sequences are known (Rall et al., 1982b) . The locus for human apo E is closely linked to the loci for apo CII and the Lutheran blood group on chromosome 19 (Myklebost et al., 1984; Gedde-Dahl et al., 1984) . Recently, the complete nucleotide sequence of the human apo E gene has been determined (Paik et al., 1985) . The major function of apo E is its mediation of the cellular uptake of specific plasma lipoproteins through an interaction with apo B,E (LDI,) receptor on extrahepatic and hepatic cell surface and with distinct hepatic apo E receptor . In addition, apo E is involved in the normal conversion of VI,DI, to the low density lipoproteins (LDI,) (Ehnholm et al., 1984) . Thus, apo E plays an important role in the metabolism of cholesterol and other lipids.
In man, the locus for apo E is polymorphic (Utermann et al., 1977; Zannis et al., 1981; Zannis et al., 1982) . Three common alleles, designated s2, ~3 and ~4, have been demonstrated to exist in various populations Wardell et al., 1982; Ghiselli et al., 1982; Cumming and Robertson, 1984; Asakawa et al., 1985; Sing and Davignon, 1985) . The three common alleles, ~2, e3 and e4, code for three common apo E isoforms, apo E2, apo E3 and apo E4, respectively and determine six apo E phenotypes (Zannis et al., 1981 ; Zannis et al., 1982; Utermann et al., 1982 ). Futhermore, rare mutant genes have been described (Chiselli et al., 1982; Weisgraber et al., 1984; Gregg et al., 1983; Yamamura et al., 1984a; Yamamura et al., 1984b) . Besides an association of apo E2 with type III hyperlipidemia (Havel, 1982) , most of apo E isoforms encoded by these rare mutant genes have been reported to be associated with hyperlipidemia or atherosclerotic diseases or both. They include apo E Bethesda (apo El) detected in a Caucasian family and apo E5 and apo E suita (apo E7) found in Japanese families (Gregg et al., 1983; Yamamura et al., 1984a; Yamamura et al., 1984b) . Apo E5 and apo E7 have been thus far detected only in Japanese patients with myocardial infarction and hyperlipidemia and in their family members (Yamamura et al., 1984b) .
The main purpose of this study is to investigate the frequency of apo E5 and apo E7 in apparently healthy Japanese. Our data suggest that the frequency of individuals with apo E5 or apo E7 is of the order of 1 ~ and much higher than that of homozygotes with apo E2/2 in Japanese.
MATERIALS AND METHODS
Subjects and samples. We studied 197 apparently healthy Japanese: 85 males and 8 females aged 35-64 years who visited the health care center of Kudanzaka hospital in Tokyo; 53 males aged 40-57 years who visited the health care center of Tsuchiura-kyodo hospital in Tsuchiura city; 51 staffs (30 males and 21 females), aged 22-43 years, of University of Tsukuba. Blood samples were taken after an overnight fast.
Laboratory procedures. Ten ul of VLDL-rich fraction was separated from 175 tA of serum by ultracentrifugation for 3 hr at 160,000 x g using Beckmann Airfuge Ultracentrifuge (Beckman Instruments, Inc., Irvine, California). To determine the phenotype of apo E, 10 pl of VLDL-rich fraction was subjected to two-dimentional (two-D) gel electrophoresis. Two-D gel electrophoresis was performed essentially according to the method of O'Farrell (1977) as previously described (Hamaguchi et aI,, 1982) with minor modifications: Ampholine mixtures of 1.4~ pH range 5-8 and 0.6~ pH range 3-10 were used in the first dimentional disc gel. After two-D gel electrophoresis, polypeptides were visualized on slab gels by the silver stain technique of Merril et al. (198l) . The apo E spots on slab gels were identified by the method of immuno-blotting (Towbin et al., 1979) , using goat anti-human apo E (Daiichi Pure Chemicals Ltd., Tokyo) and fluorescein-conjugated rabbit anti-goat IgG (Cappel Laboratories Inc., Malvern, Pennsylvania). Serum total cholesterol and triglyceride were measured enzymatically (Allain et al., 1974; Sampson et aI., 1975) : The samples from Kudanzaka hospital were analyzed on an automated analyzer (Hitachi Model 712, Hitachi Ltd., Japan) and the other samples manually Chemicals using commercial kits (Cholesterol E-Test and Triglyceride CII-Test, Wako Pure Ltd., Tokyo). Figure I shows the two-D gel electrophoresis pattern of the three most common apo E phenotypes, apo E3/3, apo E3/4 and apo E2/3. In this survey, apo E5 was found in heterozygous state with apo E2 or apo E3 in two males. Figure 2 shows the two-D gel electrophoresis pattern of apo E 2/5 phenotype, together with the data on the identification of the apo E spot on the gel by immuno-blotting. In addition to apo E5, apo E7 was also found in heterozygous state with apo E3 in one male. The two-D gel electrophoresis pattern of apo E3/7 phenotype is shown in Fig. 3 . The apo E7 spot on the slab gel was also indentified as apo E by immunoblotting (data not shown). No apo E1 was found. A, apo E2/3; B, apo E3/3; C, apo E3/4. Apo E2, apo E3, and apo E4 are indicated by E2, E3, and E4, respectively. Albumin and apolipoprotein A-I are shown by alb and AI, respectively. The polypeptide indicated by m is a useful marker for the determination of apo E phenotypes. Isoelectric focusing was from left to right and molecular weight separation from top to bottom.
RESULTS
tion that Hardy-Weinberg equilibrium is observed. The frequencies of the three common alleles, s2, ~3 and s4, are similar to those observed in Hiroshima (Asakawa et al., 1985) . However, it is noteworthy that three out of 187 subjects (1.5~) were found to have apo E5 or apo E7 in heterozygous state. Table 2 shows the serum total cholesterol and triglyceride levels of the three subjects with apo E5 or apo E7. In two individuals with apo E3/5 and apo E3/7, the serum lipid levels were normal. On the other hand, one individual with apo E2/5 had mild hypertriglyceridemia.
DISCUSSION
Apo E5 and apo E7 have been detected in about 5~ of Japanese patients with hyperlipidemia and ischemic heart disease, while they were not found among 100 healthy Japanese (Yamamura et al., 1984a; Yamamura et al., 1984b) . We also found four cases with apo E5 or apo E7 (4.3%) out of 92 patients with myocardial infarction (Hamaguchi et al., in preparation) . Yamamura et al. (1984b) observed that five of seven patients with apo E5 or apo E7 had overt atherosclerotic disease.
Based on their observations, Yamamura et al. (1984b) suggested that apo E5 and apo E7 are closely related to the development of atherosclerosis. In the present study, apo E5 and apo E7 were detected for the first time in apparently healthy subjects, with a frequency of 1.5~o. According to our data, the expected frequency of homozygotes with apo E2/2 is 0.14%. Our data suggest that the frequency of individuals with apo E5 or apo E7 is of the order of 1~ and much higher than that of homozygotes with apo E2/2 in Japanese. Two of three individuals with apo E5 or apo E7 had normal values for plasma lipid levels, though they both were more than 50 years old. They are heterozygous with apo E3. Apo E3 has normal function in both receptor binding activities and the conversion of VLDL to LDL Ehnholm et al., 1984) . On the other hand, the other individual with very rare apo E genotype, ~2/5, had mild hypertriglyceridemia. He was 36 years old. In this case, however, the existence of ~2 should be considered in the interpretation of the data. Apo E2 displays reduced apo B,E receptor binding activity Rall et al., 1982a; Rall et al., 1983) and reduced apo E receptor binding activity (Hui et al., 1984) . In addition, apo E2 appears to impede the conversion of VLDL to LDL (Ehnholm et al., 1984) . Usually e2 is associated with type III hyperlipidemia as a recessive gene. In the present case with ~2/5, it is not clear whether e5 alone was responsible for hypertriglyceridemia or the combination of e5 with ~2 was important as the etiology of hyperlipidemia. As to myocardial infarction, angina pectoris and cerebral infarction, no clinically abnormal findings were detected in all the three individuals with apo E5 or apo ET. Further genetic, epidemiologic and clinical studies as well as the analysis of functions are required to determine whether s5 and s7 act as a dominant major gene, as a recessive major gene, or as one of polymeric genes, in predisposing one to hyperlipidemia and atherosclerosis.
